论文部分内容阅读
在2003年二季度,孟山都在种子和基因组学方面销售额的增加抵消了草甘膦和其它除草剂销售的下降。二季度销售额增长了8.3%,为16.82亿美元。来自种子和基因组的毛利增长了45%,而来自农药的毛利增长了25%,这反映了孟山都业务的转移。孟山都的新总裁和CEO Hugh Grant说,上半年公司处于“良好状态”。在美国,草甘膦和选择性除草剂销售额的下降使二季度孟山都农药销售额下降10.8%,为11.94亿美元。
In the second quarter of 2003, Monsanto’s increase in sales of seeds and genomics offset the decline in sales of glyphosate and other herbicides. In the second quarter, sales rose 8.3% to $ 1.682 billion. Gross profit from seeds and genomes increased by 45% while gross profit from pesticides increased by 25%, reflecting the shift in Monsanto operations. Hugh Grant, Monsanto’s new president and CEO, said the company was in “good condition” in the first half of the year. In the United States, sales of glyphosate and selective herbicides decreased Monsanto’s pesticide sales in the second quarter by 10.8% to $ 1,194 million.